Navigation Links
ImmunoVaccine Technologies Collaborates with NRC Institute for Biodiagnostics Atlantic to measure effectiveness of DepoVax(TM) with novel MRI Imagin
Date:5/20/2009

HALIFAX, May 20 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, has announced a collaboration agreement with the National Research Council Institute for Biodiagnostics (NRC-IBD) Atlantic. This collaboration will develop new 3-D MRI technology to track the effect of IVT's DepoVax(TM) technology on reducing tumour growth.

"This research has the potential to deliver extremely sensitive MRI analysis, down to the individual cell level, and we will see, for the first time, our DepoVax(TM) formulation in action," remarked Dr. Marc Mansour, vice president R&D at IVT.

In pre-clinical studies, IVT has shown that DepoVax(TM) vaccines can eradicate cancerous tumors. This new research involves labeling liposomes, suspended in the DepoVax(TM) formulation, with iron-oxide nanoparticles. The 3-D MRI analysis will shed light on the activity of DepoVax(TM) in vivo, and allow the monitoring of tumor elimination in real time.

Current MRI techniques are well established in biomedical research. This research aims at developing highly sensitive and quantitative techniques for monitoring tumor progression and vaccine clearance in vivo.

"This collaboration means that NRC-IBD Atlantic will break new ground in developing novel MRI imaging techniques that will vastly improve the quality of information that may be acquired non-invasively," continued Mansour.

ABOUT IVT

Most recently, ImmunoVaccine Technologies presented significant advancements in its therapeutic cancer, pandemic influenza and Hepatitis B vaccine applications at BIO 2009 international convention www.convention.bio.org.

ImmunoVaccine Technologies Inc., is a privately held, vaccine development company. Through its own biotech research, patented DepoVax(TM) technology, and collaborations with partners, IVT creates vaccines with the potential to help save
'/>"/>

SOURCE ImmunoVaccine Technologies Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. ImmunoVaccine Technologies Inc. Nears Phase I Clinical Trials with Completion of Scientific Advisory Board
2. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
3. ImmunoVaccine Technologies Patents DepoVax(TM) Vaccine Platform
4. ImmunoVaccine Technologies Congratulates Dr. Ramila Philip as One of PAs Best 50 Women in Business
5. ImmunoVaccine Technologies Broadens Its Patent Protection to Japan
6. ImmunoVaccine Technologies Presents at OneMed Place Finance Forum
7. ImmunoVaccine Technologies Signs Agreement with National Institutes of Health to Explore Vaccines for HIV and Malaria
8. ImmunoVaccine Technologies Collaborates with Defence Research & Development Canada to Strengthen Canadas Ability to Deal with Biological Threats
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
11. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... FREMONT, Calif., Dec. 14 Vermillion, ... company, today announced William C. Wallen, Ph.D. ... and Development for IDEXX Laboratories, will be ... of Vermillion,s bankruptcy plan. ,, "Bill ... development experience in diagnostics and biotechnology," said ...
(Date:12/14/2009)... Dec. 14 Dyadic International, Inc. (Pink ... extended its collaboration with The Scripps Research Institute ... to re-annotate the genome of Dyadic,s patented and ... a continuation of the successful relationship between the ... Dyadic engaged Scripps to annotate the C1 genome ...
(Date:12/14/2009)... Joins with State Biotech Leaders to Develop ... and Development while Boosting Rhode Island,s Growing ... PROVIDENCE, R.I., Dec. 14 Several ... research, medicine and biotechnology gathered today at ... the importance of medical innovation in Rhode ...
(Date:12/14/2009)... ROCKAWAY, N.J., Dec. 14 The third ... Approach , published by the ... FDA-approved treatment for anthracycline extravasation.(1) Anthracyclines are ... idarubicin and epirubicin that have been used in ... the early 1970s.(2) ,, According to ...
Breaking Biology Technology:Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5
... ST. LOUIS, July 24 Monsanto Company (NYSE:,MON) ... for Roundup,Ready 2 Yield(TM) soybeans in Mexico, Australia ... European Food Safety Authority (EFSA) has,issued a positive ... for import as food or feed. Roundup Ready ...
... growth, INDIANAPOLIS, July 24 Eli Lilly ... results for the second quarter of,2008., Second-quarter ... were prepared in accordance with generally accepted accounting,principles ... by the,company during the period. Year-to-date financial results ...
... Jersey, July 24, Rosetta Genomics Ltd. (Nasdaq: ... of microRNA-based diagnostics and therapeutics, announced,today that ... Parkway,Clinical Laboratories Inc. ("Parkway"), a privately-held company ... for an aggregate,purchase price of $2,900,000, consisting ...
Other Biology Technology:Monsanto Announces Key Regulatory Approvals for Roundup Ready 2 Yield(TM) Soybeans; Product Remains on Track for 2009 Launch 2Lilly Reports Solid Second-Quarter Results 2Lilly Reports Solid Second-Quarter Results 3Lilly Reports Solid Second-Quarter Results 4Lilly Reports Solid Second-Quarter Results 5Lilly Reports Solid Second-Quarter Results 6Lilly Reports Solid Second-Quarter Results 7Lilly Reports Solid Second-Quarter Results 8Lilly Reports Solid Second-Quarter Results 9Lilly Reports Solid Second-Quarter Results 10Lilly Reports Solid Second-Quarter Results 11Lilly Reports Solid Second-Quarter Results 12Lilly Reports Solid Second-Quarter Results 13Lilly Reports Solid Second-Quarter Results 14Lilly Reports Solid Second-Quarter Results 15Lilly Reports Solid Second-Quarter Results 16Lilly Reports Solid Second-Quarter Results 17Lilly Reports Solid Second-Quarter Results 18Lilly Reports Solid Second-Quarter Results 19Lilly Reports Solid Second-Quarter Results 20Lilly Reports Solid Second-Quarter Results 21Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc. 2Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc. 3Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc. 4Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc. 5
(Date:12/11/2009)... professor of anthropology at the University of Arizona, has ... understand how violence shapes the health of those eking ... and her colleagues, research," Documenting the health consequences of ... A conceptual framework," is currently published in a special ... collaboration with the British medical journal the Lancet ...
(Date:12/11/2009)... CO December 11, 2009 Keystone Symposia ... announce the appointment of five new Keystone Symposia ... program enables five talented early-career life scientists (postdoctoral ... Symposia program development process for one year. Fellows ... well as a commitment to promoting diversity in ...
(Date:12/11/2009)... This release is available in German . ... due to more plant introductions than extinctions, plant ... homogeneous. The same species are occurring more frequently, ... not only the biological communities that are becoming ... regions. These processes have led to a loss ...
Breaking Biology News(10 mins):UA-led study grapples with health effects of low-intensity warfare 2Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 2Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 3Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 4Europe's flora is becoming impoverished 2Europe's flora is becoming impoverished 3Pharmacy Technician Employment Increasing Up to 32 25 By 2016 6823 1Pharmacy Technician Employment Increasing Up to 32 25 By 2016 6823 2Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka Seltzer Plus 28R 29 Day 26amp 3B Night Cold Formula Liquid Gels 6818 1Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka Seltzer Plus 28R 29 Day 26amp 3B Night Cold Formula Liquid Gels 6818 2Are manometric findings different between the patients with erosive and nonerosive disease 3F 62846 1Are manometric findings different between the patients with erosive and nonerosive disease 3F 62846 2
... Energy,s Argonne National Laboratory is working closely with ... of creating a cleaner Beijing and developing sustainable ... , Recently, DOE and China,s Ministry of ... at promoting large scale deployment of next-generation vehicle ...
... (KGI) today announced that Dr. Animesh Ray, KGI professor and ... the international online journal PLoS ONE that sheds ... jumping genes. , We have known for some time that ... the genome, said President Sheldon Schuster, PhD, KGIs president. Dr. ...
... Ind. -- A study by an Indiana University environmental ... variety of genetically engineered corn has the potential to ... this week by the journal Proceedings of the ... Todd V. Royer, an assistant professor in the IU ...
Other Biology News:Argonne helps China create cleaner Beijing for 2008 Olympics 2KGI professor contributes new insights on 'jumping genes' 2Study shows genetically engineered corn could affect aquatic ecosystems 2Study shows genetically engineered corn could affect aquatic ecosystems 3
...
... Synthetic Peptide: M(1) E F L P ... P T M D L E(19) PA1-072 detects ... has been successfully used in Western blot procedures. ... ~86 kDa protein representing Mint3 from AtT20 cell ...
... (AR) Competitor Assay Kits provide a sensitive ... potential AR ligands using fluorescence polarization (FP). ... domain protein tagged with His and GST ... androgen ligand (Fluormone AL Green in the ...
... for complex protein processing and production challenges. We ... you develop a solution to your problem and then ... do additional work/scale-up processes ... transfer all methodology to your own lab , ...
Biology Products: